CN102727756A - Compound powder for treating aphtha and method for preparing compound powder - Google Patents
Compound powder for treating aphtha and method for preparing compound powder Download PDFInfo
- Publication number
- CN102727756A CN102727756A CN2012102306506A CN201210230650A CN102727756A CN 102727756 A CN102727756 A CN 102727756A CN 2012102306506 A CN2012102306506 A CN 2012102306506A CN 201210230650 A CN201210230650 A CN 201210230650A CN 102727756 A CN102727756 A CN 102727756A
- Authority
- CN
- China
- Prior art keywords
- calcined
- compound powder
- tetracaine
- borax
- catechu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000843 powder Substances 0.000 title claims abstract description 31
- 208000002399 aphthous stomatitis Diseases 0.000 title claims abstract description 21
- 238000000034 method Methods 0.000 title claims abstract description 8
- 150000001875 compounds Chemical class 0.000 title abstract 8
- 210000003038 endothelium Anatomy 0.000 claims abstract description 20
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 19
- GKCBAIGFKIBETG-UHFFFAOYSA-N tetracaine Chemical compound CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 GKCBAIGFKIBETG-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229960002372 tetracaine Drugs 0.000 claims abstract description 19
- 229910021538 borax Inorganic materials 0.000 claims abstract description 18
- 235000010339 sodium tetraborate Nutrition 0.000 claims abstract description 18
- 239000004328 sodium tetraborate Substances 0.000 claims abstract description 18
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims description 17
- 235000006226 Areca catechu Nutrition 0.000 claims description 17
- 241001161070 Calomela Species 0.000 claims description 17
- 238000013329 compounding Methods 0.000 claims description 17
- 239000009286 sanguis draxonis Substances 0.000 claims description 17
- 244000293323 Cosmos caudatus Species 0.000 claims description 13
- 235000005956 Cosmos caudatus Nutrition 0.000 claims description 13
- 239000003814 drug Substances 0.000 claims description 12
- 239000002994 raw material Substances 0.000 claims description 11
- 229940079593 drug Drugs 0.000 claims description 4
- 239000012467 final product Substances 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 244000080767 Areca catechu Species 0.000 claims 5
- 244000235603 Acacia catechu Species 0.000 abstract description 13
- 230000000694 effects Effects 0.000 abstract description 10
- 230000036407 pain Effects 0.000 abstract description 10
- 230000008901 benefit Effects 0.000 abstract description 5
- 238000002360 preparation method Methods 0.000 abstract description 4
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 235000006020 Acacia catechu Nutrition 0.000 abstract 1
- 241001313855 Bletilla Species 0.000 abstract 1
- 241000270295 Serpentes Species 0.000 abstract 1
- 239000001560 acacia catechu Substances 0.000 abstract 1
- 229940037003 alum Drugs 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- 229940075397 calomel Drugs 0.000 abstract 1
- 239000006071 cream Substances 0.000 abstract 1
- ZOMNIUBKTOKEHS-UHFFFAOYSA-L dimercury dichloride Chemical compound Cl[Hg][Hg]Cl ZOMNIUBKTOKEHS-UHFFFAOYSA-L 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 239000009136 dragon's blood Substances 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 229940126672 traditional medicines Drugs 0.000 abstract 1
- 229940126673 western medicines Drugs 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 description 12
- 238000005469 granulation Methods 0.000 description 8
- 230000003179 granulation Effects 0.000 description 8
- 230000001225 therapeutic effect Effects 0.000 description 7
- 208000025865 Ulcer Diseases 0.000 description 5
- 231100000397 ulcer Toxicity 0.000 description 5
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000001338 necrotic effect Effects 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 208000007117 Oral Ulcer Diseases 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 208000000412 Avitaminosis Diseases 0.000 description 1
- 244000241235 Citrullus lanatus Species 0.000 description 1
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000371997 Eriocheir sinensis Species 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010044278 Trace element deficiency Diseases 0.000 description 1
- 208000000558 Varicose Ulcer Diseases 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 150000002333 glycines Chemical class 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000002691 topical anesthesia Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 208000030401 vitamin deficiency disease Diseases 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a compound powder for treating aphtha and a method for preparing the compound powder. The compound powder is composed by dragon blood, endothelium corneum gigeriae galli, pearl, crab cream, snake slough, fossilizid, acacia catechu, calcined borax, dried alum, common bletilla pseudobulb, calomel, borneol and tetracaine; and all the ingredients are ground and mixed to obtain the compound powder. The compound powder has the advantages that the compound powder fully plays the advantages of integrated traditional and western medicines, can quickly stop pain, eliminates the pain of a patient, quickly cures, and has no toxic and side effects and a simple preparation method.
Description
Technical field
The present invention relates to a kind of medicine of treating aphtha, specifically a kind of compounding powder of treating aphtha and preparation method thereof belongs to aphtha medicine field.
Background technology
Aphtha is called oral ulcer again, is the superficial ulcer that occurs on the oral mucosa, and big I is big or small, circular or oval from the grain of rice to Semen Glycines, and ulcer surface is recessed, congested on every side.Ulcer has characteristics such as periodicity, recurrent and self limiting, good sending out in lip, cheek, lingual margin etc.The cause of disease and mechanism of causing a disease are still indeterminate.Inducement possibly be local wound, psychentonia, food, medicine, hormonal readiness change and vitamin or trace element deficiency.Systemic disease, heredity, immunity and microorganism possibly play an important role in its generation, development.Treatment is main with topical therapeutic mainly, and severe patient needs whole body therapeutic, does not have the efficacious therapy medicine clinically temporarily, " BINGPENG SAN ", " watermelon crystal " though etc. certain curative effect is arranged, but its analgesic effect is relatively poor, it is slower to heal.
Summary of the invention
In order to address the above problem, the present invention has designed a kind of compounding powder of treating aphtha and preparation method thereof, gives full play to the bonded advantage of Chinese medicine and western medicine, and patient's misery is eliminated in pain relieving rapidly, very fast healing, and have no side effect, method for preparing is simple.
Technical scheme of the present invention is:
A kind of compounding powder of treating aphtha is made up of Sanguis Draxonis, Endothelium Corneum Gigeriae Galli, Margarita, crab roe, Periostracum Serpentis, Os Draconis (calcined), catechu, Borax(calcined), dried Alumen, Pseudobulbus Bletillae (Rhizoma Bletillae), Calomelas, Borneolum Syntheticum and tetracaine;
The weight portion of each raw material is:
Sanguis Draxonis 12-18g, Endothelium Corneum Gigeriae Galli 18-22g, Margarita 18-22g, crab roe 18-22g, Periostracum Serpentis 8-12g, Os Draconis (calcined) 18-22g, catechu 12-18g, Borax(calcined) 35-45g, dried Alumen 35-45g, Pseudobulbus Bletillae (Rhizoma Bletillae) 18-22g, Calomelas 8-12g, Borneolum Syntheticum 8-12g and tetracaine 0.5-1g.
Further, the weight portion of each raw material is:
Sanguis Draxonis 12g, Endothelium Corneum Gigeriae Galli 18g, Margarita 18g, crab roe 18g, Periostracum Serpentis 8g, Os Draconis (calcined) 18g, catechu 12g, Borax(calcined) 35g, dried Alumen 35g, Pseudobulbus Bletillae (Rhizoma Bletillae) 18g, Calomelas 8g, Borneolum Syntheticum 8g and tetracaine 0.5g.
Further, the weight portion of each raw material is:
Sanguis Draxonis 18g, Endothelium Corneum Gigeriae Galli 22g, Margarita 22g, crab roe 22g, Periostracum Serpentis 12g, Os Draconis (calcined) 22g, catechu 18g, Borax(calcined) 45g, dried Alumen 45g, Pseudobulbus Bletillae (Rhizoma Bletillae) 22g, Calomelas 12g, Borneolum Syntheticum 12g and tetracaine 1g.
Preferably, the weight portion of each raw material is:
Sanguis Draxonis 15g, Endothelium Corneum Gigeriae Galli 20g, Margarita 20g, crab roe 20g, Periostracum Serpentis 10g, Os Draconis (calcined) 20g, catechu 15g, Borax(calcined) 40g, dried Alumen 40g, Pseudobulbus Bletillae (Rhizoma Bletillae) 20g, Calomelas 10g, Borneolum Syntheticum 10g and tetracaine 0.75g.
Wherein, Sanguis Draxonis has promoting blood circulation to remove blood stasis, and skin ulcer is held back in analgesic therapy, the effect of hemostasia and promoting granulation; Endothelium Corneum Gigeriae Galli is ground external into powder, promoting tissue regeneration and wound healing after the stir-fry; Margarita has the effect of convergence granulation promoting, is applicable to that throat rots, aphtha of the mouth and tongue, ulcer do not close up for a long time; Crab roe is got Huang and dried and form for female Eriocheir sinensis cooks, and has the effect of nourshing blood and promoting blood circulation, removing the necrotic tissue and promoting granulation, and is remarkable for the therapeutic effect of aphtha; Periostracum Serpentis, removing the necrotic tissue and promoting granulation, remarkable for the therapeutic effect of aphtha; Os Draconis (calcined) has the effect of promoting tissue regeneration and ulcer healing, and is remarkable for the therapeutic effect of aphtha; Catechu, removing dampness is held back skin ulcer; Pseudobulbus Bletillae (Rhizoma Bletillae), the granulation promoting pain relieving; The convergence of drawing out pus by applying a plaster to the affected part of Calomelas, putrefaction removing; Borneolum Syntheticum, reducing swelling and alleviating pain; Tetracaine has the effect of topical anesthesia.
In the powder of the present invention, dried Alumen has the secret effect of convergence system, and Borax(calcined), crab roe have the effect of removing the necrotic tissue and promoting granulation, Margarita convergence granulation promoting, and Borneolum Syntheticum ability reducing swelling and alleviating pain, Periostracum Serpentis has the usefulness with Pi Zhipi by theory of Chinese medical science; Tetracaine can pain relieving, can cut off the vicious cycle of pain focus again, improves curative effect, shortens the course of disease, is our principal agent.More than 13 flavor Chinese and western drugses mutual compatibilities, removing the necrotic tissue and promoting granulation, the convergence pain relieving, boil on the nape opposite the mouth have a good therapeutic effect.
The method for preparing of above-mentioned powder is:
(1) according to each drug component of aforementioned proportion weighing;
(2) with the little stir-fry of Periostracum Serpentis, Endothelium Corneum Gigeriae Galli is fried carbon, puts into all the other each components, puts into pulverizer after the stirring and pulverizes, and crosses 100 mesh sieves, gets final product.
The method for using of above-mentioned powder is: with product with cotton rod dip in get after, apply and to give on the oral ulcer surface every day 4-5 time.
The invention has the advantages that: give full play to the bonded advantage of Chinese medicine and western medicine, patient's misery is eliminated in pain relieving rapidly, very fast healing, and have no side effect, method for preparing is simple.
The specific embodiment
Below the preferred embodiments of the present invention are described, should be appreciated that preferred embodiment described herein only is used for explanation and explains the present invention, and be not used in qualification the present invention.
Embodiment 1
A kind of compounding powder of treating aphtha is made up of Sanguis Draxonis, Endothelium Corneum Gigeriae Galli, Margarita, crab roe, Periostracum Serpentis, Os Draconis (calcined), catechu, Borax(calcined), dried Alumen, Pseudobulbus Bletillae (Rhizoma Bletillae), Calomelas, Borneolum Syntheticum and tetracaine;
The weight portion of each raw material is:
Sanguis Draxonis 12g, Endothelium Corneum Gigeriae Galli 18g, Margarita 18g, crab roe 18g, Periostracum Serpentis 8g, Os Draconis (calcined) 18g, catechu 12g, Borax(calcined) 35g, dried Alumen 35g, Pseudobulbus Bletillae (Rhizoma Bletillae) 18g, Calomelas 8g, Borneolum Syntheticum 8g and tetracaine 0.5g.
Embodiment 2
A kind of compounding powder of treating aphtha is made up of Sanguis Draxonis, Endothelium Corneum Gigeriae Galli, Margarita, crab roe, Periostracum Serpentis, Os Draconis (calcined), catechu, Borax(calcined), dried Alumen, Pseudobulbus Bletillae (Rhizoma Bletillae), Calomelas, Borneolum Syntheticum and tetracaine;
The weight portion of each raw material is:
Sanguis Draxonis 18g, Endothelium Corneum Gigeriae Galli 22g, Margarita 22g, crab roe 22g, Periostracum Serpentis 12g, Os Draconis (calcined) 22g, catechu 18g, Borax(calcined) 45g, dried Alumen 45g, Pseudobulbus Bletillae (Rhizoma Bletillae) 22g, Calomelas 12g, Borneolum Syntheticum 12g and tetracaine 1g.
Embodiment 3
A kind of compounding powder of treating aphtha is made up of Sanguis Draxonis, Endothelium Corneum Gigeriae Galli, Margarita, crab roe, Periostracum Serpentis, Os Draconis (calcined), catechu, Borax(calcined), dried Alumen, Pseudobulbus Bletillae (Rhizoma Bletillae), Calomelas, Borneolum Syntheticum and tetracaine;
The weight portion of each raw material is:
Sanguis Draxonis 15g, Endothelium Corneum Gigeriae Galli 20g, Margarita 20g, crab roe 20g, Periostracum Serpentis 10g, Os Draconis (calcined) 20g, catechu 15g, Borax(calcined) 40g, dried Alumen 40g, Pseudobulbus Bletillae (Rhizoma Bletillae) 20g, Calomelas 10g, Borneolum Syntheticum 10g and tetracaine 0.75g.
Embodiment 4
A kind of method for preparing the said compounding powder of embodiment 1-3 comprises:
(1) according to each drug component of aforementioned proportion weighing;
(2) with the little stir-fry of Periostracum Serpentis, Endothelium Corneum Gigeriae Galli is fried carbon, puts into all the other each components, puts into pulverizer after the stirring and pulverizes, and crosses 100 mesh sieves, gets final product.
Select aphtha patient 60 examples, be divided into treatment group and matched group at random, every group 15 example, two groups of cases at age, sex, wound area through statistical procedures, P＞0.05, no significant difference.The described three kinds of compounding powders of embodiment 1-3 are organized as treatment, and matched group is with GUILIN XIGUA SHUANG (Sanjin Pharmaceutical Co., Ltd., Guilin produce, the accurate word Z45021599 of traditional Chinese medicines), and the treatment group is with powder of the present invention every day 4-5 time, affected part external application.Four groups of all inactive other medicines of cases, all the other conditions are identical, and observed result after 7 days sees the following form:
From table 1, can find out three days cure rates: matched group 9 examples, account for 60%, treatment is organized more than 11 examples, accounts for more than 73%; Average cure time: in the matched group 84 hours, treatment group 67 hours.Three days cure rates of treatment group all are superior to matched group with average cure rate, and do not have toxicity.Prove the evident in efficacy of powder treatment aphtha of the present invention; Wherein, treatment group is best with the therapeutic effect of embodiment 3.
What should explain at last is: the above is merely the preferred embodiments of the present invention; Be not limited to the present invention; Although the present invention has been carried out detailed explanation with reference to previous embodiment; For a person skilled in the art, it still can be made amendment to the technical scheme that aforementioned each embodiment put down in writing, and perhaps part technical characterictic wherein is equal to replacement.All within spirit of the present invention and principle, any modification of being done, be equal to replacement, improvement etc., all should be included within protection scope of the present invention.
Claims (5)
1. compounding powder of treating aphtha is characterized in that:
Form by Sanguis Draxonis, Endothelium Corneum Gigeriae Galli, Margarita, crab roe, Periostracum Serpentis, Os Draconis (calcined), catechu, Borax(calcined), dried Alumen, Pseudobulbus Bletillae (Rhizoma Bletillae), Calomelas, Borneolum Syntheticum and tetracaine;
The weight portion of each raw material is:
Sanguis Draxonis 12-18g, Endothelium Corneum Gigeriae Galli 18-22g, Margarita 18-22g, crab roe 18-22g, Periostracum Serpentis 8-12g, Os Draconis (calcined) 18-22g, catechu 12-18g, Borax(calcined) 35-45g, dried Alumen 35-45g, Pseudobulbus Bletillae (Rhizoma Bletillae) 18-22g, Calomelas 8-12g, Borneolum Syntheticum 8-12g and tetracaine 0.5-1g.
2. compounding powder according to claim 1 is characterized in that, the weight portion of said each raw material of compounding powder is:
Sanguis Draxonis 12g, Endothelium Corneum Gigeriae Galli 18g, Margarita 18g, crab roe 18g, Periostracum Serpentis 8g, Os Draconis (calcined) 18g, catechu 12g, Borax(calcined) 35g, dried Alumen 35g, Pseudobulbus Bletillae (Rhizoma Bletillae) 18g, Calomelas 8g, Borneolum Syntheticum 8g and tetracaine 0.5g.
3. compounding powder according to claim 1 is characterized in that, the weight portion of said each raw material of compounding powder is:
Sanguis Draxonis 18g, Endothelium Corneum Gigeriae Galli 22g, Margarita 22g, crab roe 22g, Periostracum Serpentis 12g, Os Draconis (calcined) 22g, catechu 18g, Borax(calcined) 45g, dried Alumen 45g, Pseudobulbus Bletillae (Rhizoma Bletillae) 22g, Calomelas 12g, Borneolum Syntheticum 12g and tetracaine 1g.
4. compounding powder according to claim 1 is characterized in that, the weight portion of said each raw material of compounding powder is:
Sanguis Draxonis 15g, Endothelium Corneum Gigeriae Galli 20g, Margarita 20g, crab roe 20g, Periostracum Serpentis 10g, Os Draconis (calcined) 20g, catechu 15g, Borax(calcined) 40g, dried Alumen 40g, Pseudobulbus Bletillae (Rhizoma Bletillae) 20g, Calomelas 10g, Borneolum Syntheticum 10g and tetracaine 0.75g.
5. the method for preparing like any described compounding powder among the right 1-4 is characterized in that: according to each drug component of aforementioned proportion weighing; With the little stir-fry of Periostracum Serpentis, grind, put into all the other each components, put into pulverizer after the stirring and pulverize, cross 100 mesh sieves, get final product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012102306506A CN102727756B (en) | 2012-07-05 | 2012-07-05 | Compound powder for treating aphtha and method for preparing compound powder |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012102306506A CN102727756B (en) | 2012-07-05 | 2012-07-05 | Compound powder for treating aphtha and method for preparing compound powder |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102727756A true CN102727756A (en) | 2012-10-17 |
| CN102727756B CN102727756B (en) | 2013-07-31 |
Family
ID=46984520
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012102306506A Active CN102727756B (en) | 2012-07-05 | 2012-07-05 | Compound powder for treating aphtha and method for preparing compound powder |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102727756B (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1260186A (en) * | 1998-12-29 | 2000-07-19 | 陈方明 | Kouchuangjin (wiping out aphtha) and its preparation technology |
| CN1650989A (en) * | 2004-12-15 | 2005-08-10 | 胡少勇 | Chinese medicine oral cavity adherent emplastrum and its preparation method |
| CN101185691A (en) * | 2007-12-11 | 2008-05-28 | 叶志群 | Powder agent medicine for treating infantile aphtha |
| CN101444555A (en) * | 2008-11-08 | 2009-06-03 | 青岛市市立医院 | Purely Chinese traditional medical film for curing oral ulcer and method for preparing same |
| CN102048848A (en) * | 2009-11-04 | 2011-05-11 | 陈德路 | Pure traditional Chinese medicine powder for treating aphtha |
| CN102178859A (en) * | 2011-04-19 | 2011-09-14 | 黄帅 | Formula of plaster for treating innominate gall of red and swollen tall sores and preparation method thereof |
-
2012
- 2012-07-05 CN CN2012102306506A patent/CN102727756B/en active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1260186A (en) * | 1998-12-29 | 2000-07-19 | 陈方明 | Kouchuangjin (wiping out aphtha) and its preparation technology |
| CN1650989A (en) * | 2004-12-15 | 2005-08-10 | 胡少勇 | Chinese medicine oral cavity adherent emplastrum and its preparation method |
| CN101185691A (en) * | 2007-12-11 | 2008-05-28 | 叶志群 | Powder agent medicine for treating infantile aphtha |
| CN101444555A (en) * | 2008-11-08 | 2009-06-03 | 青岛市市立医院 | Purely Chinese traditional medical film for curing oral ulcer and method for preparing same |
| CN102048848A (en) * | 2009-11-04 | 2011-05-11 | 陈德路 | Pure traditional Chinese medicine powder for treating aphtha |
| CN102178859A (en) * | 2011-04-19 | 2011-09-14 | 黄帅 | Formula of plaster for treating innominate gall of red and swollen tall sores and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102727756B (en) | 2013-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105147985B (en) | A kind of preparation with pharynx-clearing throat-benefiting moistening lung effect | |
| CN103961559A (en) | Styptic powder with dendrobium officinale | |
| CN102973674A (en) | Eczema eliminating capsule | |
| CN102727756B (en) | Compound powder for treating aphtha and method for preparing compound powder | |
| CN101874618B (en) | Acne-removing, skin-nourishing and health-care tea and preparation method thereof | |
| CN102091301A (en) | Traditional Chinese medicine composition for soothing nerves and relieving depression and application thereof | |
| CN102178843B (en) | Chinese medicinal powder for treating dental ulcer and stomatitis | |
| CN102319271B (en) | Bedsore nursing powder | |
| CN104666671A (en) | Anti-cancer analgesic medicine of Chinese yew and preparation method of anti-cancer analgesic medicine | |
| CN105641377A (en) | Traditional Chinese medicinal decoction for treating swine bronchial pneumonia and preparation method of traditional Chinese medicinal decoction | |
| CN102068526A (en) | Chinese medicament for treating oral ulcer | |
| CN102671047A (en) | Chinese medicinal composition for treating acne and chloasma | |
| CN2768815Y (en) | Chinese herbal medicine bag for protecting umbilicus, stopping pain and antidiarrheal | |
| CN101543544A (en) | Chinese medicinal preparation for treating nervous headache | |
| CN105943584A (en) | Medicine for treating dental ulcer | |
| CN105582376A (en) | Externally-used traditional Chinese medicine for treating rubella | |
| CN104173877A (en) | Traditional Chinese medicine preparation for quick wound healing and preparation method of traditional Chinese medicine preparation for quick wound healing | |
| CN104958653A (en) | Traditional Chinese medicine composition for treating tuberculosis | |
| CN102319325B (en) | Pearl beautifying product and preparation method thereof | |
| CN108578595A (en) | A kind of pharmaceutical composition that treating chronic itch and its application | |
| CN101284072B (en) | Externally used Chinese medicine for curing the dentalgia | |
| CN107929462A (en) | A kind of clearing heat for detumescence analgesic drug product | |
| CN103705618A (en) | Medicine for treating beriberi | |
| CN108543022A (en) | A kind of formula for controlling abnormal sweating | |
| CN102327293B (en) | Traditional Chinese medicine combination for treating aphtha and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: NANTONG FANGDU HIGH-TECH VENTURE PARK SERVICE CO., Free format text: FORMER OWNER: YANG FAXIANG Effective date: 20140717 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 262700 WEIFANG, SHANDONG PROVINCE TO: 226112 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20140717 Address after: 226112, Jiangsu, Nantong Haimen town Sanxing village 15 groups Patentee after: Nantong Textile Science and Technology Pioneer Park Service Co.,Ltd. Address before: 262700 Shandong city of Weifang province since the middle of Shouguang Shouguang City Kang Lu Guangming hospital Patentee before: Yang Faxiang |
|
| CP01 | Change in the name or title of a patent holder |
Address after: 226112, Jiangsu, Nantong Haimen town Sanxing village 15 groups Patentee after: Nantong textile Capital Management Co.,Ltd. Address before: 226112, Jiangsu, Nantong Haimen town Sanxing village 15 groups Patentee before: Nantong Textile Science and Technology Pioneer Park Service Co.,Ltd. |
|
| CP01 | Change in the name or title of a patent holder | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20200616 Address after: Sanxing Zhen Nan Cun, Haimen City, Nantong City, Jiangsu Province Patentee after: Jiangsu Dieshiqiao Investment Co.,Ltd. Address before: 226112, Jiangsu, Nantong Haimen town Sanxing village 15 groups Patentee before: Nantong textile Capital Management Co.,Ltd. |